SWTX
SpringWorks Therapeutics, Inc.
- Latest sale
- $1.1M
- Mar 3 · Routine
- Form 4 sales
- 50
- On record
- Form 144 notices
- 2
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineFeb 10 2025
Sold 29,750 shares at $54.36 ($1.6M)
Pichl Daniel, Chief People Officer
10b5-1 planSold 37% of holdings ($4.4M position)50,762 shares leftFiling
- 2 Form 4 saleRoutineFeb 14 +4 days
Sold 400 shares at $60.00 ($24k)
Lynch Daniel, Director
10b5-1 planSold 0.3% of holdings ($7.9M position)130,544 shares leftFiling
- 3 Form 4 saleRoutineFeb 14 same day
Sold 10,672 shares at $59.92 ($639k)
Islam Saqib, Chief Executive Officer
10b5-1 planSold 1% of holdings ($64.4M position)1.1M shares left0.2x usual sizeFiling
- 4 Form 4 saleRoutineFeb 20 +6 days
Sold 47,600 shares at $60.22 ($2.9M)
Lynch Daniel, Director
10b5-1 planSold 36.5% of holdings ($7.9M position)82,944 shares leftFiling
- 5 Form 4 saleRoutineFeb 20 same day
Sold 1,016 shares at $61.19 ($62k)
Ashar Bhavesh, Chief Commercial Officer
10b5-1 planSold 1.6% of holdings ($3.9M position)62,053 shares leftFiling
- 6 Form 4 saleRoutineFeb 20 same day
Sold 29,328 shares at $60.30 ($1.8M)
Islam Saqib, Chief Executive Officer
10b5-1 planSold 2.8% of holdings ($64.2M position)1M shares left0.6x usual sizeFiling
- 7 Form 4 saleRoutineMar 3 +11 days
Sold 49,000 shares at $54.24 ($2.7M)
Islam Saqib, Chief Executive Officer
10b5-1 planSold 4.9% of holdings ($54.4M position)954,869 shares left1x usual sizeFiling
- 8 Form 4 saleRoutineMar 3 same day
Sold 20,000 shares at $54.23 ($1.1M)
Edris Badreddin, Chief Operating Officer
10b5-1 planSold 10.5% of holdings ($10.3M position)169,712 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (52)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 20,000 | $1.1M | 10.5% | Routine | SEC |
| Mar 3, 2025 | Islam Saqib | Chief Executive Officer | Form 4 sale | 49,000 | $2.7M | 4.9% | Routine | SEC |
| Feb 20, 2025 | Islam Saqib | Chief Executive Officer | Form 4 sale | 29,328 | $1.8M | 2.8% | Routine | SEC |
| Feb 20, 2025 | Ashar Bhavesh | Chief Commercial Officer | Form 4 sale | 1,016 | $62k | 1.6% | Routine | SEC |
| Feb 20, 2025 | Lynch Daniel | Director | Form 4 sale | 47,600 | $2.9M | 36.5% | Routine | SEC |
| Feb 14, 2025 | Islam Saqib | Chief Executive Officer | Form 4 sale | 10,672 | $639k | 1.0% | Routine | SEC |
| Feb 14, 2025 | Lynch Daniel | Director | Form 4 sale | 400 | $24k | 0.3% | Routine | SEC |
| Feb 10, 2025 | Pichl Daniel | Chief People Officer | Form 4 sale | 29,750 | $1.6M | 37.0% | Routine | SEC |
| Feb 10, 2025 | Lynch Daniel | Director | Form 4 sale | 175,000 | $9.5M | 57.2% | Routine | SEC |
| Feb 10, 2025 | Islam Saqib | Chief Executive Officer | Form 4 sale | 48,000 | $2.6M | 4.6% | Routine | SEC |
| Feb 10, 2025 | Hambleton Julie | Director | Form 4 sale | 13,774 | $730k | 77.1% | Unusual | SEC |
| Feb 10, 2025 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 30,000 | $1.6M | 13.7% | Routine | SEC |
| Dec 3, 2024 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 20,000 | $839k | 8.7% | Routine | SEC |
| Dec 2, 2024 | Islam Saqib | Chief Executive Officer | Form 4 sale | 49,000 | $2M | 4.6% | Routine | SEC |
| Sep 3, 2024 | Islam Saqib | Chief Executive Officer | Form 4 sale | 49,000 | $2M | 4.4% | Routine | SEC |
| Sep 3, 2024 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 20,000 | $813k | 8.0% | Routine | SEC |
| Jun 3, 2024 | Islam Saqib | Chief Executive Officer | Form 4 sale | 49,000 | $2M | 4.2% | Routine | SEC |
| Jun 3, 2024 | Hambleton Julie | Director | Form 4 sale | 4,648 | $186k | 53.2% | Routine | SEC |
| Jun 3, 2024 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 20,000 | $801k | 7.4% | Routine | SEC |
| Feb 16, 2024 | Pichl Daniel | Chief People Officer | Form 4 sale | 15,000 | $752k | 24.9% | Routine | SEC |
| Feb 5, 2024 | Ashar Bhavesh | Chief Commercial Officer | Form 4 sale | 8,056 | $381k | 12.2% | No plan | SEC |
| Feb 2, 2024 | Pichl Daniel | Chief People Officer | Form 4 sale | 26,181 | $1.2M | 36.7% | Routine | SEC |
| Nov 2, 2023 | Bc Sw, LP | Former Affiliate | Form 144 notice | 500,000 | $12M | Notice | SEC | |
| Jul 19, 2023 | Hambleton Julie | Director | Form 4 sale | 2,418 | $71k | 34.2% | Routine | SEC |
| Jun 20, 2023 | Hambleton Julie | Director | Form 4 sale | 2,400 | $65k | 25.4% | Routine | SEC |
| Jun 20, 2023 | Hambleton Julie | Board Member | Form 144 notice | 4,818 | $130k | Notice | SEC | |
| Mar 16, 2023 | Schwartz Jeffrey Lawrence | Director | Form 4 sale | 1.8M | $49.9M | 36.2% | Unusual | SEC |
| Mar 15, 2023 | Hambleton Julie | Director | Form 4 sale | 1,106 | $35k | 18.7% | Plan not stated | SEC |
| Jan 26, 2023 | Pichl Daniel | Chief People Officer | Form 4 sale | 858 | $27k | 2.4% | Plan not stated | SEC |
| Sep 12, 2022 | OrbiMed Capital GP VI LLC | 10% owner | Form 4 sale | 153,897 | $4.9M | 2.7% | Plan not stated | SEC |
| Aug 9, 2022 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 274,568 | $10.5M | 4.6% | Unusual | SEC |
| Oct 20, 2021 | Islam Saqib | Chief Executive Officer | Form 4 sale | 10,083 | $592k | 1.3% | Plan not stated | SEC |
| Oct 19, 2021 | Islam Saqib | Chief Executive Officer | Form 4 sale | 52,417 | $3.1M | 6.4% | Plan not stated | SEC |
| Oct 13, 2021 | Smith L. Mary | Chief Development Officer | Form 4 sale | 10,000 | $560k | 5.6% | Plan not stated | SEC |
| Aug 10, 2021 | Bc Sw, LP | 10% owner | Form 4 sale | 1M | $70.3M | 17.1% | Plan not stated | SEC |
| Jul 20, 2021 | Islam Saqib | Chief Executive Officer | Form 4 sale | 62,500 | $4.8M | 7.1% | Plan not stated | SEC |
| Jul 13, 2021 | Smith L. Mary | Chief Development Officer | Form 4 sale | 10,000 | $809k | 5.6% | Plan not stated | SEC |
| Jul 1, 2021 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 15,959 | $1.4M | 0.3% | Plan not stated | SEC |
| Jul 1, 2021 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 32,000 | $2.7M | 9.6% | Plan not stated | SEC |
| Jun 28, 2021 | OrbiMed Capital GP VI LLC | 10% owner | Form 4 sale | 6,502 | $554k | 0.1% | Plan not stated | SEC |
| Jun 25, 2021 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 56,634 | $4.8M | 0.9% | Plan not stated | SEC |
| Jun 10, 2021 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 30,852 | $2.6M | 0.5% | Plan not stated | SEC |
| Jun 9, 2021 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 48,053 | $4.1M | 0.8% | Plan not stated | SEC |
| Apr 28, 2021 | Squinto Stephen P | Director, 10% owner | Form 4 sale | 19,432 | $1.5M | 13.4% | Plan not stated | SEC |
| Apr 20, 2021 | Islam Saqib | Chief Executive Officer | Form 4 sale | 62,500 | $4.3M | 6.6% | Plan not stated | SEC |
| Apr 15, 2021 | Squinto Stephen P | Director, 10% owner | Form 4 sale | 1,568 | $118k | 1.1% | Plan not stated | SEC |
| Apr 13, 2021 | Smith L. Mary | Chief Development Officer | Form 4 sale | 10,000 | $681k | 5.6% | Plan not stated | SEC |
| Mar 9, 2021 | Koppel Adam | 10% owner | Form 4 sale | 1.4M | $104M | 19.9% | Plan not stated | SEC |
| Mar 1, 2021 | OrbiMed Capital GP VI LLC | 10% owner | Form 4 sale | 1.2M | $101M | 16.5% | Plan not stated | SEC |
| Jan 25, 2021 | Edris Badreddin | Chief Operating Officer | Form 4 sale | 32,000 | $2.7M | 10.9% | Plan not stated | SEC |
| Jan 20, 2021 | Smith L. Mary | Chief Development Officer | Form 4 sale | 10,000 | $787k | 5.6% | Plan not stated | SEC |
| Jan 20, 2021 | Islam Saqib | Chief Executive Officer | Form 4 sale | 62,500 | $4.9M | 4.9% | Plan not stated | SEC |